Pacific Biosciences of California, Inc. (PACB)
 NASDAQ: PACB · Real-Time Price · USD
 1.940
 -0.070 (-3.48%)
  At close: Oct 30, 2025, 4:00 PM EDT
2.000
 +0.060 (3.09%)
  After-hours: Oct 30, 2025, 7:55 PM EDT
PACB Analyst Ratings
Total Analysts  
 7
Consensus Rating  
 Buy
Price Target  
 $1.90
Upside  
 -2.06%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date | 
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $1.25 → $1.5 | Hold | Maintains | $1.25 → $1.5 | -22.68% | Aug 11, 2025 | 
| Barclays | Barclays | Hold Maintains $2 → $1.5 | Hold | Maintains | $2 → $1.5 | -22.68% | Jun 25, 2025 | 
| Piper Sandler | Piper Sandler | Hold Maintains $2 → $1.25 | Hold | Maintains | $2 → $1.25 | -35.57% | May 15, 2025 | 
| Stephens & Co. | Stephens & Co. | Buy Reiterates $1.8 | Buy | Reiterates | $1.8 | -7.22% | May 15, 2025 | 
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +54.64% | Apr 10, 2025 | 
| Scotiabank | Scotiabank | Buy Maintains $6 → $2 | Buy | Maintains | $6 → $2 | +3.09% | Mar 25, 2025 | 
| Piper Sandler | Piper Sandler | Hold Reiterates $2.5 → $2 | Hold | Reiterates | $2.5 → $2 | +3.09% | Feb 20, 2025 | 
| Goldman Sachs | Goldman Sachs | Hold Maintains $1.75 → $1.5 | Hold | Maintains | $1.75 → $1.5 | -22.68% | Feb 18, 2025 | 
| Stephens & Co. | Stephens & Co. | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +28.87% | Feb 18, 2025 | 
| Stephens & Co. | Stephens & Co. | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +28.87% | Feb 14, 2025 | 
| Goldman Sachs | Goldman Sachs | Hold Maintains $2.25 → $1.75 | Hold | Maintains | $2.25 → $1.75 | -9.79% | Jan 23, 2025 | 
| UBS | UBS | Strong Buy → Hold Downgrades $2 | Strong Buy → Hold | Downgrades | $2 | +3.09% | Nov 11, 2024 | 
| Scotiabank | Scotiabank | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +209.28% | Nov 11, 2024 | 
| Piper Sandler | Piper Sandler | Hold Maintains $2 → $2.5 | Hold | Maintains | $2 → $2.5 | +28.87% | Nov 11, 2024 | 
| Scotiabank | Scotiabank | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +260.82% | Aug 28, 2024 | 
| Stephens & Co. | Stephens & Co. | Buy Maintains $3.5 → $2.5 | Buy | Maintains | $3.5 → $2.5 | +28.87% | Aug 13, 2024 | 
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.